Clinical Trial Update: Peptide Vaccine and S-1/CPT-11 Therapy for Patients With Unresectable Advanced Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a peptide vaccine in combination with S-1 and irinotecan (CPT-11) for unresectable advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• S-1 (tegafur/gimeracil/oteracil)
• peptide vaccine

Snippet

Sponsor: Kazuhiko Yoshimatsu | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED